Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

Call for Abstracts - First International Meeting on Meningioma

Abstract submission deadline February 15, 2016

Read Full Story

SNO Meeting Highlights 2015

  Launched for the first time at the 20th Annual Meeting of the Society for ...

Read Full Story

SNO Mourns the Loss of Christina Meyers

A longtime colleague and friend...

Read Full Story
View All News

February
19

9th Annual International Symposium on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery

Read Full Story

March
03

Twenty Second Annual Blood-Brain Barrier Consortium Meeting in Collaboration with the International Brain Barriers Society

Read Full Story

March
24

SNOLA 2016 - Update on Neuro-Oncology

Read Full Story

Neuro-Oncology Impact Factor Rises

The Society for Neuro-Oncology is pleased to announce that the impact factor for Neuro-Oncology has risen to 6.180, putting the journal among the top ten titles in Clinical Neurology by the Science Citation Index.

This new, higher ranking reinforces Neuro-Oncology’s position as the leading journal in the field.

With a wealth of peer-reviewed articles and reviews, topical symposia, abstracts of annual meetings, and society news from around the world, the journal continues its mission to provide superior and rapid publication of information in all areas of neuro-oncology.

The three recent most highly cited papers are free to read via the below links.

 

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

Authors: de Groot, John F.; Fuller, Gregory; Kumar, Ashok J.; et al.

 

A multigene predictor of outcome in glioblastoma

Authors: Colman, Howard; Zhang, Li; Sulman, Erik P.; et al.

 

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

Authors: Raizer, Jeffrey J.; Abrey, Lauren E.; Lassman, Andrew B.; et al.

 

For more information

http://neuro-oncology.oxfordjournals.org/